Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.23
+0.06 (0.97%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $294.27 million as of June 8, 2026. Its market cap has increased by 28.73% in one year.
Market Cap
294.27M
Enterprise Value
224.33M
1-Year Change
28.73%
Ranking
Category
Stock Price
$6.23
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $294.27M, a decrease of -45.34%. That is a compound annual growth rate of -9.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 294.27M | 2.47% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 303.90M |
| Nautilus Biotechnology | 303.72M |
| Invivyd | 303.45M |
| Fennec Pharmaceuticals | 302.21M |
| Rocket Pharmaceuticals | 300.28M |
| Humacyte | 299.73M |
| Neumora Therapeutics | 297.78M |
| Lineage Cell Therapeutics | 296.66M |